The link between psoriasis, obesity, and fatty liver highlights how systemic inflammation can persist and fuel other health complications, even when skin symptoms improve.

A study published in the assessed the association of liver fibrosis with cumulative methotrexate dose and other liver fibrosis risk factors in patients with a history of moderate-to-severe psoriasis.

Philadelphia, May 20, 2025 – New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics, inflammation can linger, leading to broader ...

While patients with psoriasis-- a chronic skin condition -- respond well to treatment with biologics, inflammation can linger, leading to broader health implications such as obesity and ...

Researchers from King’s College London evaluated 25 different measurements of body fat and found that those related to the ...

New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics, inflammation can linger, leading to broader health implications such as ...

Psoriasis, a chronic inflammatory skin condition characterized by dry and scaly skin lesions, affects about 7.5 million people in the United States. Psoriasis results from abnormal proliferation ...

Scientists believe the hormone hepcidin, when produced in the skin, may be the root cause of psoriasis -- a chronic and sometimes debilitating skin disease that affects 2-3% of the global population.

This study reveals hepcidin's significant role in psoriasis, linking iron retention to inflammation and keratinocyte growth, suggesting new therapeutic targets.

Research from 2022 showed that glutathione levels were lower in people with psoriasis. This research suggests that the use of dimethyl fumarate, a medication typically for treating multiple ...

New Delhi, May 20 : While patients with psoriasis -- a chronic skin condition -- respond well to treatment with biologics, inflammation can linger, leading to broader health implications such as ...